US FDA approves Jazz Pharma’s Ziihera to treat adults with …
2 days ago · Jazz Pharmaceuticals plc announced the US Food and Drug Administration (FDA) accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use …
Syngene embarks on evaluating the bioequivalence of an …
2 days ago · Syngene has embarked on evaluating bioequivalence of an injectable for type-2 diabetes and weight management. This was after a global pharma company was scouting for …
Novartis upgrades mid-term guidance and highlights deep …
1 day ago · Novartis announced an upgrade to its mid-term guidance, in advance of its Meet Novartis Management event for investors and analysts in London. Previous guidance for +5% …
Pharmanovia partners with Lindis Biotech to commercialise …
2 days ago · Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has …
Pfizer’s Hympavzi receives European marketing approval to treat …
3 days ago · Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for Hympavzi (marstacimab) for the routine prophylaxis of bleeding episodes in …
Merck’s phase 3 trial of subcutaneous pembrolizumab with ...
3 days ago · Merck, known as MSD outside of the United States and Canada, announced positive topline results from the pivotal phase 3 MK-3475A-D77 trial. The trial is evaluating the …
Late-breaking data reinforce long-term benefits of Abbott's …
3 days ago · Abbott, a global healthcare leader, announced late-breaking data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to treat people with atrial fibrillation (AFib) who …
Azurity Pharma gets US FDA approval for Danziten tablets, the first …
Nov 16, 2024 · Azurity Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved Danziten, the first and only nilotinib with no mealtime restrictions …
US FDA grants accelerated approval to Novartis’ Scemblix for adult ...
Oct 31, 2024 · Novartis announced that Scemblix (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed …
PTC Therapeutics’ gene therapy, Kebilidi to treat AADC deficiency ...
Nov 15, 2024 · Warren, New Jersey. Friday, November 15, 2024, 10:00 Hrs [IST] PTC Therapeutics, Inc., a global biopharmaceutical company, announced the US Food and Drug …